<h1>Digital-led company named Leader in 2025 life sciences AI and analytics assessment for Gen AI solutions, pricing, and patient analytics</h1> A digital-led business transformation and services company was named a 'Leader' in a 2025 life sciences AI and analytics commercial assessment by an independent research firm. The recognition cites the company's Gen AI-powered proprietary solutions, domain-centric analytics, innovative pricing models, customer-centric approach, and expanded advanced analytics capabilities across channel effectiveness, competitive benchmarking, and patient data analytics. An acquisition that deepened capabilities in field force enablement and market/competitive intelligence was noted as a differentiator. The release includes customary forward-looking safe-harbor disclosures about risks and uncertainties.